MDGL earnings
Madrigal Pharma (MDGL) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
MDGL earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Jul 30, 2026 | -1.99 | -2.68 | 25.75% | $364.25M |
| Q1 2026 | May 6, 2026 | -3.25 | -3.61 | 9.97% | $311.34M |
| Q4 2025 | Feb 19, 2026 | -2.57 | 0.04 | -6525.00% | $321.08M |
| Q3 2025 | Nov 4, 2025 | -5.08 | -2.04 | -149.38% | $287.27M |
| Q2 2025 | Aug 5, 2025 | -1.90 | -3.48 | 45.40% | $212.80M |
| Q1 2025 | May 1, 2025 | -3.32 | -3.62 | 8.29% | $137.25M |
| Q4 2024 | Feb 26, 2025 | -2.71 | -4.32 | 37.27% | $103.32M |
| Q3 2024 | Oct 31, 2024 | -4.92 | -6.94 | 29.11% | $62.17M |
| Q2 2024 | Aug 7, 2024 | -7.10 | -7.55 | 5.96% | $14.64M |
| Q1 2024 | May 7, 2024 | -7.38 | -6.06 | -21.78% | – |
| Q4 2023 | Feb 28, 2024 | -5.68 | -5.32 | -6.77% | – |
| Q3 2023 | Nov 6, 2023 | -5.34 | -4.78 | -11.72% | – |
| Aug 8, 2023 | -4.69 | -4.47 | -4.92% | – | |
| May 9, 2023 | -4.23 | -4.98 | 15.06% | – | |
| Feb 23, 2023 | -4.98 | -4.41 | -12.93% | – | |
| Nov 3, 2022 | -4.75 | -4.05 | -17.28% | – | |
| Aug 4, 2022 | -4.14 | -3.76 | -10.11% | – | |
| May 9, 2022 | -3.36 | -3.75 | 10.40% | – | |
| Feb 24, 2022 | -3.78 | -3.92 | 3.57% | – | |
| Nov 4, 2021 | -3.79 | -3.89 | 2.57% | – |
- MDGL reports next on Nov 3, 2026, with EPS of -0.90 expected.
- MDGL beat EPS estimates in 39 of its last 76 reports.
Updated 2026-11-03 00:44 UTC